EFFICACY AND SAFETY OF RUXOLITINIB IN TURKISH PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A MULTICENTER AND RETROSPECTIVE ANALYSIS

dc.contributor.authorSoyer, N.
dc.contributor.authorTurgut, M.
dc.contributor.authorHaznedaroglu, I.
dc.contributor.authorYilmaz, F.
dc.contributor.authorAydogdu, I.
dc.contributor.authorPir, A.
dc.contributor.authorKarakus, V.
dc.contributor.authorOzgur, G.
dc.contributor.authorKis, C.
dc.contributor.authorCeran, F.
dc.contributor.authorIlhan, G.
dc.contributor.authorOzkan, M.
dc.contributor.authorArslaner, M.
dc.contributor.authorInce, I.
dc.contributor.authorYavasoglu, I.
dc.date.accessioned2019-10-27T11:05:06Z
dc.date.available2019-10-27T11:05:06Z
dc.date.issued2017
dc.departmentEge Üniversitesien_US
dc.description8th International Eurasian Hematology Oncology Congress (EHOC) -- OCT 18-21, 2017 -- Istanbul, TURKEYen_US
dc.identifier.endpageS19en_US
dc.identifier.issn0145-2126
dc.identifier.issn1873-5835
dc.identifier.startpageS19en_US
dc.identifier.urihttps://hdl.handle.net/11454/31604
dc.identifier.volume61en_US
dc.identifier.wosWOS:000416742600048en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherPergamon-Elsevier Science Ltden_US
dc.relation.ispartofLeukemia Researchen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleEFFICACY AND SAFETY OF RUXOLITINIB IN TURKISH PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A MULTICENTER AND RETROSPECTIVE ANALYSISen_US
dc.typeConference Objecten_US

Dosyalar